In this context, we investigated the prognostic and predictive significance of the NOS2/ARG1 axis and immune cell ratios in chemotherapy combined with cetuximab in wt-KRAS metastatic colorectal cancer. This evidence concerns the gene NOS2 and metastatic colorectal cancer.